Skip to main content

Want a detailed portfolio tracker?

Opthea (OPT) P/E

Opthea (OPT) P/E from Feb 6, 2026 to Jul 21, 2026. The TTM Opthea (OPT) P/E is -4.61. You can export chart.

P/E

Annual P/E change of Opthea (OPT)

YearP/EChange
2026-4.61N/A

Comparison Opthea (OPT) P/E with competitors

Opthea (OPT) P/E is -4.61.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.62%
FGENFibroGen Inc0.24-105.20%
CHRSCoherus Biosciences Inc0.85-118.39%
FBIOFortress Biotech Inc0.95-120.56%
ORMPOramed Pharmaceuticals Inc1.50-132.57%
AGENAgenus Inc3.01-165.21%
INVAInnoviva Inc3.15-168.34%
VXRTVaxart Inc3.55-176.92%
CRMDCorMedix Inc3.63-178.62%
CVACCureVac N.V.4.45-196.33%
GLPGGalapagos NV4.86-205.28%
SRPTSarepta Therapeutics Inc4.88-205.79%
ABEOAbeona Therapeutics Inc5.39-216.74%
ABUSArbutus Biopharma Corp5.60-221.25%
ZVRAZevra Therapeutics Inc5.89-227.56%
SPROSpero Therapeutics Inc6.23-234.96%
CGENCompugen Ltd6.31-236.81%
RIGLRigel Pharmaceuticals6.87-248.90%
SLXNSilexion Therapeutics Corp7.30-258.09%
OMEROmeros Corporation9.26-300.62%
AUPHAurinia Pharmaceuticals Inc9.58-307.69%
PLXProtalix BioTherapeutics Inc10.89-335.99%
ACADAcadia Pharmaceuticals Inc11.73-354.13%
TBPHTheravance Biopharma Inc12.26-365.70%
ADMAAdma Biologics Inc12.42-369.08%
HRMYHarmony Biosciences Holdings Inc13.82-399.46%
SABSSAB Biotherapeutics Inc14.14-406.30%
NAGENiagen Bioscience Inc14.82-421.08%
INCYIncyte Corp15.82-442.84%
REGNRegeneron Pharmaceuticals Inc15.86-443.58%
PBYIPuma Biotechnology Inc17.32-475.20%
CPRXCatalyst Pharmaceuticals Inc17.44-477.88%
EXELExelixis Inc17.54-480.02%
TGTXTG Therapeutics Inc18.97-510.96%
MDXGMimedx Group Inc20.55-545.33%
XOMAXOMA Royalty Corp22.87-595.66%
ARGXArgen X SE24.30-626.51%
CTMXCytomX Therapeutics Inc24.82-637.84%
XOMAOXOMA Royalty Corp25.34-649.19%
HALOHalozyme Therapeutics Inc25.62-655.23%
XOMAPXOMA Royalty Corp25.67-656.24%
VRTXVertex Pharmaceuticals Inc27.99-706.61%
RPRXRoyalty Pharma plc - Class A28.69-721.62%
SLNOSoleno Therapeutics Inc29.02-728.72%
ASNDAscendis Pharma A/S30.09-751.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-921.50%
APLSApellis Pharmaceuticals Inc39.02-945.54%
BMRNBiomarin Pharmaceutical Inc42.21-1014.68%
KRYSKrystal Biotech Inc45.34-1082.53%
ONCBeiGene Ltd69.54-1606.85%
PHARPharming Group N.V.75.03-1725.71%
TECHBio-Techne Corp101.96-2309.31%
VCELVericel Corp109.92-2481.85%
ALNYAlnylam Pharmaceuticals Inc117.96-2656.15%
GMABGenmab140.29-3139.92%
TLXTelix Pharmaceuticals Ltd162.15-3613.64%
CORTCorcept Therapeutics Inc212.86-4712.35%